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Objectives: Published data on splenic preservation during distal pancreatectomy have been inconsis-
tent. We hypothesized that patients undergoing spleen-preserving distal pancreatectomy (SPDP) would
have fewer infectious and non-infectious complications than those undergoing en bloc distal pancreate-
ctomy with splenectomy (DPS), and that their haematological parameters would be consistent with
splenic function.
Methods: Of 97 patients who underwent either SPDP using the Warshaw technique or en bloc DPS, 78
met our study inclusion criteria. Records were reviewed for data on age, gender, resection, indications for
resection, operative time, blood loss, transfusion requirements, hospital stay, infectious complications,
any other complications, postoperative white blood cell (WBC) and platelet counts. Data were analysed
using the chi-squared test, the two-sided Mann–Whitney–Wilcoxon text, and simple and multiple logistic
regression analyses. A P-value of <0.05 was considered significant.
Results: Patients undergoing SPDP had a shorter length of stay and shorter operative time, were more
likely to be completed laparoscopically, less likely to require re-operation, and had fewer infectious and
non-infectious complications. However, these differences were not statistically significant. In multiple
logistic regression analyses, patient age and length of hospital stay were both significant predictors of the
occurrence of non-infectious complications (P = 0.04 and P = 0.006, respectively). Blood transfusion was
a significant predictor of postoperative morbidity (P = 0.013 for infectious complications; P = 0.018 for
non-infectious complications). White blood cell count was a statistically significant predictor of infectious
(P = 0.02) and non-infectious (P = 0.04) complications, whereas platelet count was not. Patients who
underwent DPS had statistically significantly higher WBC and platelet counts immediately postoperatively
and at 6 months compared with SPDP patients. Postoperative mortality in both the SPDP and DPS
groups was 0%. None of the 30 SPDP patients had evidence of splenic infarction. Pancreatic leaks
occurred in 18% of patients in the SPDP group, compared with 8% in the DPS group (P < 0.05).
Conclusions: Spleen-preserving distal pancreatectomy using the Warshaw technique is associated with
lower postoperative morbidity than DPS. Lower WBC and platelet counts suggest better splenic function
in SPDP patients.
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Introduction
Distal pancreatectomy is considered to be a safe procedure for
benign, premalignant and malignant tumours of the body and tail
of the pancreas. Traditionally, this operation includes en bloc
splenectomy. Because of the important immunological function
of the spleen and the risks for overwhelming post-splenectomy
infection (OPSI), hypercoagulability and haematological malig-
nancies after splenectomy,1 several authorities have highlighted
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the benefits of splenic preservation in distal pancreatectomy. Pub-
lished data regarding the benefits of spleen-preserving distal pan-
createctomy (SPDP) are conflicting. Shoup et al.2 reported that
SPDP was associated with fewer perioperative complications and
shorter hospital stay. Conversely, Holdsworth et al.,3 in a collective
critical review of the literature, did not demonstrate an increased
frequency of infections or postoperative complications as a result
of splenectomy. Because the reported incidence of pancreatic leaks
is significantly higher after SPDP,4,5 the role of splenic preservation
in distal pancreatectomy has been debated.
Spleen-preserving distal pancreatectomy was initially
described in 1943 by Mallet-Guy and Vachon.6 In this operation
the splenic artery and vein are preserved by ligating the pancre-
atic tributaries. Warshaw7 described an alternative technique in
which the spleen is perfused by preserving the short gastric
vessels and the splenic vessels are divided with the pancreas.
Both techniques are feasible with minimally invasive approaches,
which are well described and safe to perform.8,9 However, many
authors suggest that splenic vessel preservation is more time-
consuming, is associated with greater blood loss and is techni-
cally more demanding, especially when it is performed
laparoscopically.10–13
Functional asplenia is difficult to assess and several diagnostic
techniques have been proposed,14–18 although their sensitivity and
specificity have been disputed. Persistent left upper quadrant
(LUQ) pain and computed tomography (CT) with i.v. contrast
have also been utilized to diagnose splenic infarctions after
SPDP.19 Thrombocytosis and leukocytosis20,21 are well-known hae-
matological responses to splenectomy and may assist in determin-
ing splenic function after SPDP.
Theoretically, SPDP should confer benefit when compared with
distal pancreatectomy with splenectomy (DPS), but few data are
available to support this. We hypothesized that patients undergo-
ing SPDP would have fewer infectious and non-infectious com-
plications than those undergoing DPS, and would maintain
haematological parameters consistent with splenic function.
Materials and methods
The Henry Ford Health System Institutional Review Board
approved this study. We reviewed hospital records using
common procedure terminology (CPT) codes for distal pancre-
atectomies performed between January 1996 and January 2010
and identified 97 patients. Patients who had undergone distal
pancreatectomy for trauma and invading malignant tumours
requiring en bloc resection of other intra-abdominal organs
were excluded. One other patient, who had undergone concomi-
tant liver transplantation, was also excluded. Thus, this study
referred to a cohort of 78 patients who had undergone open or
laparoscopic distal pancreatectomy, with or without splenec-
tomy. These operations were performed by 12 different surgeons,
although the majority of cases (54/78, 70%) were performed by
one surgeon.
Patient data
Data collected included age, gender, operation performed (open
vs. laparoscopic, with or without splenectomy), histopathology,
postoperative length of stay, postoperative complications,
re-operation, length of operation, estimated blood loss (EBL),
packed red blood cell (PRBC) units transfused, and pre- and
postoperative white blood cell (WBC) count and platelet count
(on postoperative day 7 and at 6 months). Postoperative compli-
cations were dichotomized to infectious and non-infectious com-
plications. Urinary tract infections (UTIs) and intra-abdominal
abscesses were determined according to the results of microbiol-
ogy cultures. Pneumonia was diagnosed based on chest X-ray
findings in conjunction with fever and high WBC count. Surgical
site infections were determined according to need to open and
drain the incision. Pancreatic leak was defined as drainage of
>30 ml from a Jackson–Pratt (JP) drain, with an amylase level
three times that of serum. Leukocytosis was defined by a WBC
count >10.6/mm3 and thrombocytosis platelet count of >450/
mm3. Records were also reviewed for patient complaints of LUQ
pain and CT scans of the abdomen in the course of assessing for
splenic infarction in patients who had undergone SPDP.
Operative techniques
Because multiple surgeons were involved in the care of these
patients, the operative technique was not standardized. However,
in general the techniques for DPS and SPDP are well described
and basic principles were followed.
In DPS the lesser sac is entered through the gastrocolic
omentum. The splenocolic ligament and short gastric vessels are
divided. After the spleen is mobilized, the retropancreatic attach-
ments are also divided. The body of the pancreas is then divided
and the pancreatic remnant secured with a stapling, suture liga-
ture or both. In this series, a JP drain was routinely used at the
pancreatic remnant.
In SPDP the lesser sac is entered through the gastrocolic liga-
ment and the greater curvature is mobilized carefully in order to
ensure that the short gastric vessels remain intact. The body and
tail of the pancreas are mobilized. The splenic artery and vein at
the hilum are divided. The pancreas along with the proximal
splenic artery and vein are then divided and secured with a sta-
pling device, suture ligature or both.
Both operations were performed through a standard open lap-
arotomy or using a laparoscopic approach described previously.22
In some procedures, both open and laparoscopic, the pancreatic
remnant was treated with fibrin glue in an attempt to reduce the
incidence of pancreatic leak.23
Statistical analysis
All statistical analyses were performed using sas Version 9.2 (SAS
Institute, Inc., Cary, NC, USA). Descriptive statistics for patient
and operative characteristics were used for patients who under-
went SPDP and DPS. Quantitative variables were presented
as mean, standard deviation (SD), minimum, median and
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maximum values. Categorical variables were presented as counts
and percentages. Perioperative infectious and non-infectious
complications were summarized with counts and percentages for
patients who underwent SPDP and DPS, respectively. Because a
patient could have more than one complication, the total number
of complications exceeded the patient sample size. Chi-squared
tests were used to determine whether or not there were statistically
significant differences in the occurrence of infectious and non-
infectious complications (presence or absence) between the SPDP
and DPS patient groups. The association between DPS and the
presence or absence of infectious or non-infectious complications
after adjusting for patient and operative characteristics was tested
in a multiple logistic regression model. Incidences of periopera-
tive infectious and non-infectious complications were further
broken down according to whether patients underwent laparo-
scopic or open procedures in both the SPDP and DPS groups. A
two-sided Mann–Whitney–Wilcoxon test was used to establish
whether or not differences in the distribution of either WBC or
platelet counts (at day 7 and at 6 months) between DPS and SPDP
patients were statistically significant. The effects of splenectomy
onWBC and platelet counts after adjusting for patient and opera-
tive characteristics were tested in a multiple linear regression
model. A multiple logistic regression model was used to test
whether or not DPS had a significant effect on WBC and platelet
counts while adjusting for infectious complications. Both WBC
and platelet counts were normalized using a log transformation. A
simple logistic regression model was used to test whether or not
WBC and platelet counts were significant predictors of infectious
and non-infectious complications. Means and SDs of WBC and
platelet counts were then broken down according to the occur-
rence of infectious and non-infectious complications in both the
SPDP and DPS groups. Differences were considered statistically
significant at P < 0.05.
Results
A total of 78 patients who underwent DPS or SPDP were enrolled
in the study. Their mean age was 58.1 years (range: 21–86 years);
35% (27/78) were men, 62% (48/78) underwent splenectomy and
17% (13/78) underwent laparoscopic distal pancreatectomy. Both
DPS and SPDP were performed for intraductal papillary muci-
nous neoplasms (IPMNs) (16/78, 21%), endocrine tumours (16/
78, 21%), pancreatic adenocarcinomas (16/78, 21%),mucinous or
serous cystadenomas (14/78, 18%), chronic pancreatitis (10/78,
13%) and other reasons (splenic vein thrombosis, lymphoid
hyperplasia, accessory spleen) (6/78, 8%) (Table 1). Infectious
complications occurred in a higher proportion of patients in the
DPS group compared with the SPDP group, but this difference
was not statistically significant (P = 0.1) (Table 2). There was no
difference between the groups in the incidence of non-infectious
Table 1 Patient and operative characteristics
Variable Splenectomy (DPS group, n = 48) No splenectomy (SPDP group, n = 30) P-value
Min, median, max Min, median, max
Age, years, mean (SD) 56.1 (16.6) 21.0, 58.5, 86.0 60.1 (13.4) 26.0, 60.0, 85.0 0.459
Postoperative LoS, days, mean (SD) 9.9 (10.5) 3.0, 7.0, 69.0 6.8 (5.0) 2.0, 6.0, 24.0 0.036
Length of operation, mins, mean (SD) 204.6 (84.8) 65.0, 190.0, 480.0 154.1 (65.7) 70.0, 132.5, 345.0 0.003
Histopathological condition, n (%) 0.537
Endocrine tumour 8 (16.7%) 8 (26.7%)
IPMN 8 (16.7%) 8 (26.7%)
Pancreatic adenocarcinoma 12 (25.0%) 4 (13.3%)
Mucinous serous cystadenoma 9 (18.8%) 5 (16.7%)
Chronic pancreatitis 6 (12.5%) 4 (13.3%)
Other 5 (10.4%) 1 (3.3%)
Gender, n (%) 0.626
Male 18 (37.5%) 9 (30.0%)
Female 30 (62.5%) 21 (70.0%)
Laparoscopic vs. open surgery, n (%) 0.004
Laparoscopic 3 (6.3%) 10 (33.3%)
Open 45 (93.8%) 20 (66.7%)
Re-operation required, n (%) 0.516
Yes 8 (16.7%) 3 (10.0%)
No 40 (83.3%) 27 (90.0%)
DPS, distal pancreatectomy with splenectomy; SPDP, spleen-preserving distal pancreatectomy; SD, standard deviation; LoS, length of stay; IPMN,
intraductal papillary mucinous neoplasm.
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complications (Table 3) or in incidences of infectious and non-
infectious complications after adjusting for patient and operative
characteristics (P = 0.3 and P = 0.4, respectively). However, age
[odds ratio (OR) 1.05, 95% confidence interval (CI) 1.00–1.10; P
= 0.04] and length of hospital stay (OR 1.26, 95% CI 1.07–1.48; P
= 0.006) were both significantly associated with the occurrence of
non-infectious complications as determined by multiple logistic
regression analysis. Postoperative non-infectious complications
occurred in three (23%) of the 13 patients who underwent lap-
aroscopic distal pancreatectomy (all three patients underwent lap-
aroscopic SPDP) and in 30 (46%) of the 65 patients who
underwent open surgery (P < 0.01). Infection rates were 34% in
the laparoscopy group and 28% in the open-surgery group. Blood
transfusion was a statistically significant predictor of infectious
and non-infectious complications [OR 1.27, 95% CI 1.05–1.52 (P
= 0.01) and OR 1.29, 95% CI 1.05–1.60 (P = 0.02), respectively].
Estimated blood loss was not a significant predictor of infectious
or non-infectious complications (P = 0.2 and P = 0.3, respec-
tively). Patients in the DPS group had significantly higher median
WBC and platelet counts on postoperative day 7 (P < 0.001 and P
< 0.001, respectively). This group also showed significantly higher
WBC and platelet counts at 6 months post-surgery (P = 0.006 and
P < 0.001, respectively) (Table 4). Distal pancreatectomy with
splenectomy had a significant effect on WBC after adjusting for
infectious complications (P < 0.001). When controlling for DPS,
infectious complications also had a significant effect on WBC
count (P = 0.006). Distal pancreatectomy with splenectomy had a
significant effect on platelet count after adjusting for infectious
complications (P < 0.001). However, when controlling for sple-
nectomy, infectious complications had no significant effect on
platelet count (P = 0.9). White blood cell count was a statistically
significant predictor of both infectious (P = 0.02) and non-
infectious (P = 0.04) complications. Conversely, platelet count was
not associated with postoperative infections (P = 0.4) or other
morbidities (P = 0.6) (Table 5). Older patients were more likely to
exhibit a haematological response. Specifically, for each increase in
age of 1 year, the odds of a non-infectious complication increased
by 0.05. Postoperative mortality in both the SPDP and DPS
groups was 0%.
All SPDP patients (30/30, 100%) attended a follow-up appoint-
ment within 3 months of surgery. No patient complained of per-
sistent LUQ pain. Eleven of 30 SPDP patients were given a CT scan
of the abdomen with i.v. contrast at 2–6months postoperatively to
assess or follow up for intra-abdominal fluid collections or for
cancer staging. None of these patients (0%) had evidence of
splenic infarction. Of the patients who underwent SPDP, 18%
developed pancreatic leaks compared with 8% in the DPS group
(P < 0.05). None of our splenectomy patients have thus far devel-
oped OPSI.
Discussion
The results of our study suggest that patients undergoing SPDP
tended to have fewer infectious complications, although this dif-
ference did not reach statistical significance. Theoretically, pre-
serving the immunological functions of the spleen can help to
avoid the occurrence of serious complications, such as OPSI,
thrombosis and malignancy. These complications are more
common in the paediatric population and when splenectomy is
performed for malignancy. According to our data, the only disad-
vantage of SPDP is that it involves higher rates of pancreatic
fistula. This complication did not appear to prolong hospital stay
and did not require treatment beyond the prophylactically placed
drain. Drains were removed in clinic when output was <30 ml/
Table 2 Summary of infectious complications
Infectious
complication
DPS group (n = 51
complications)
SPDP group (n = 31
complications)
None 32 (62.8%) 25 (80.7%)
Pneumonia 8 (15.7%) 1 (3.2%)
Urinary tract infection 5 (9.8%) 4 (12.9%)
Clostridium difficile 2 (3.9%) 1 (3.2%)
Bacteraemia 2 (3.9%) 0 (0%)
Wound infection 2 (3.9%) 0 (0%)
DPS, distal pancreatectomy with splenectomy; SPDP, spleen-preserving
distal pancreatectomy.
Table 3 Summary of non-infectious complications
Non-infectious
complication
DPS group
(n = 51
complications)
SPDP group
(n = 34
complications)
None 30 (58.8%) 22 (64.7%)
Pancreatic leak 4 (7.8%) 6 (17.7%)
Deep vein thrombosis 2 (3.9%) 1 (2.9%)
Ileus 2 (3.9%) 1 (2.9%)
Bleeding 2 (3.9%) 1 (2.9%)
Afib with RVR 1 (2.0%) 0 (0%)
Atrial flutter 1 (2.0%) 0 (0%)
Gastric fistula 1 (2.0%) 0 (0%)
Hypotension 1 (2.0%) 0 (0%)
Intra-abdominal abscess 1 (2.0%) 0 (0%)
Myocardial infarction 0 (0%) 1 (2.9%)
NSTEMI 1 (2.0%) 0 (0%)
Postoperative diabetes 0 (0%) 1 (2.9%)
Pulmonary oedema 1 (2.0%) 0 (0%)
Renal failure 1 (2.0%) 0 (0%)
Respiratory failure 1 (2.0%) 0 (0%)
Retained foreign body 1 (2.0%) 0 (0%)
Stroke 0 (0%) 1 (2.9%)
Urinary retention 1 (2.0%) 0 (0%)
DPS, distal pancreatectomy with splenectomy; SPDP, spleen-preserving
distal pancreatectomy; Afib with RVR, atrial fibrillation with rapid
ventricular response; NSTEMI, non-ST segment elevation myocardial
infarction.
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day. We also demonstrated that SPDP as described by Warshaw7
provided adequate perfusion to the splenic parenchyma via the
short gastric vessels: we did not identify any clinically significant
splenic infarctions and the haematological parameters of WBC
and platelet counts suggested splenic function. Age and length of
stay were associated with the occurrence of non-infectious post-
operative complications. However, increased length of stay is a
result and not a cause of the occurrence of postoperative compli-
cations. Blood transfusion was significantly associated with the
occurrence of infectious and non-infectious complications,
whereas, curiously and importantly, EBL was not. Pancreatic
pathology (benign vs. malignant) does not appear to influence
postoperative outcomes (P = 0.6 for infections; P = 0.2 for other
complications). Open distal pancreatectomy was a statistically sig-
nificant predictor of postoperative morbidity compared with the
laparoscopic approach. Patients who underwent laparoscopic DPS
were less likely to develop a complication compared with those
who underwent laparoscopic SPDP (0% vs. 30%). It could be
argued that ‘easier’ resections are more likely to be performed
laparoscopically; although this is true, the fact that EBL, as a
measure of case difficulty, was not associated with postoperative
morbidity suggests that case difficulty may not be an important
factor in the postoperative course.
We did not have data on direct measures of immunological
competence; however, we did use surrogates. Distal pancreatec-
tomy with splenectomy was associated with a statistically signifi-
cant increase in postoperativeWBC and platelet counts, even after
adjusting for infections, and operative and patient characteristics.
Leukocytosis in the DPS group was associated with an increased
occurrence of infectious and non-infectious complications, but
thrombocytosis was not. High WBC counts were not noticed in
the SPDP cohort and none of these patients developed splenic
infarcts, implying that splenic function is preserved in SPDP
patients. To our knowledge, no reports using direct measurements
of immunological competence have appeared in any of the studies
on spleen-preserving pancreatectomy, including those on the
Warshaw technique, those using Technetium 99m-labelled scans,
those using the detection of Howell–Jolly bodies, and those using
the detection of pitted erythrocytes. Therefore, all we are left with
are these indirect surrogates.We acknowledge that we do not fully
understand the clinical significance of WBC and platelet counts in
this setting.
In a meta-analysis of 5902 patients who had undergone sple-
nectomy, Holdsworth et al.3 demonstrated in adults a risk for
infection of 0.9% and a mortality rate of 0.8%, suggesting that
splenectomy can be performed safely. In a retrospective study of
259 patients who underwent distal pancreatectomy with or
without splenectomy at Massachusetts General Hospital, Rod-
riguez et al.24 reported that SPDP was associated with shorter
hospital stay, shorter operative time (2.5 h vs. 3.1 h; P < 0.001) and
less blood loss (300 ml vs. 500 ml; P < 0.001). Spleen-preserving
distal pancreatectomy was not a significant predictor of postop-
erative morbidity, although patients in the DPS group were more
likely to suffer complications (P = 0.4). These results are consistent
with our data. Shoup et al.2 published their experience at Memo-
rial Sloan–Kettering Cancer Center in a retrospective review of
125 patients who underwent either SPDP or DPS for benign
disease. They reported rates of postoperative complications of
39% in the SPDP group and 49% in the DPS group and a signifi-
cantly higher infection rate among splenectomy patients (28% vs.
9%; P = 0.01). They did not identify any differences in hospital
stay, length of surgery or blood transfusion requirements. Ald-
ridge and Williamson25 reported lower complication rates in DPS
(24%) compared with SPDP (20%) patients, but this difference
Table 4 Association between splenectomy and white blood cell (WBC) and platelet counts
Variable n Splenectomy (n = 48) n No splenectomy (n = 30) P-value
Mean  SD Min, median, max Mean  SD Min, median, max
WBC count at PoD 7 46 14.9  6.3 6.5, 14.1, 14.9 22 8.9  2.1 5.2, 8.6, 14.9 <0.001
Platelet count at PoD 7 46 499.2  254.6 89.0, 453.5, 1115.0 22 269.7  119.6 97.0, 262.0, 595.0 <0.001
WBC count at 6 months 33 11.5  11.6 4.1, 9.4, 73.5 17 7.0  2.3 3.3, 6.8, 11.9 0.006
Platelet count at 6 months 33 387.3  168.0 28.0, 357.0, 899.0 17 233.5  81.6 106.0, 218.0, 400.0 <0.001
SD, standard deviation; PoD, postoperative day.
Table 5 Summary of white blood cell (WBC) and platelet counts by the presence or absence of infectious complications and the presence
or absence of splenectomy
Variable Splenectomy No splenectomy
Infection
(n = 16)
Mean  SD
No infection
(n = 32)
Mean  SD
Infection
(n = 5)
Mean  SD
No infection
(n = 25)
Mean  SD
WBC count at PoD 7 17.7  8.7 13.4  4.0 10.9  3.9 8.5  1.3
Platelet count at PoD 7 519.4  266.1 488.4  252.2 244.3  182.6 275.3  107.7
SD, standard deviation; PoD, postoperative day.
742 HPB
HPB 2011, 13, 738–744 © 2011 International Hepato-Pancreato-Biliary Association
was not statistically significant. Benoist et al.26 enrolled 15 patients
who had undergone SPDP or DPS for benign pancreatic disease
(except chronic pancreatitis) and demonstrated rates of pancre-
atic fistula of 40% in the splenic preservation group compared
with 12% in the splenectomy cohort (P < 0.05). Intra-abdominal
abscesses were also more frequently observed in the SPDP group
(P < 0.05). In a series of 235 patients, Lillemoe et al.27 did not
identify any differences in morbidity, mortality, operative time or
blood loss when comparing SPDP with DPS patients. They also
reported an unexplained longer hospital stay among SPDP
patients (P < 0.008). Richardson and Scott-Conner28 reported
comparable complication rates (40% vs. 36%), operative time and
length of stay in DPS and SPDP patients. Nau et al.29 did not
identify any differences in morbidity, hospital stay, blood loss or
operative time when comparing laparoscopic distal pancreatec-
tomy, with and without splenectomy, suggesting that splenic con-
servation can be performed safely with minimally invasive
techniques. Analogous results were reported by Pryor et al.,30 who
performed a retrospective review of eight patients who underwent
laparoscopic distal pancreatectomy, with and without splenec-
tomy. Recently, Beane et al.19 published favourable outcomes in
patients in whom the splenic vessels were preserved compared
with those undergoing a Warshaw procedure. Surprisingly, these
authors demonstrated less blood loss (P < 0.05), fewer pancreatic
leaks (P = non-significant), fewer splenic infarctions (P < 0.05),
shorter hospital stay (P < 0.05) and less overall morbidity in
patients who underwent distal pancreatectomy with splenic vessel
preservation compared with those who underwent distal pancre-
atectomy with conservation of the short gastric vessels or DPS.
Knowledge of splenic artery anatomic variations is critical
when ligating splenic vessels in distal pancreatectomies. Pandey
et al.31 studied 320 cadavers and revealed that the splenic artery
may follow a suprapancreatic (74%), enteropancreatic (19%),
intrapancreatic (5%) or retropancreatic (3%) course. The splenic
artery may divide into two (63%), four (19%), six (10%) or more
than six (6%) terminal branches, or may course through the
hilum without dividing (3%).
Our study has significant limitations. Firstly, our sample size
was small, especially when performing multivariate analyses. It is
likely that some of the statistical tests were insufficiently powered
to detect differences between variables. This was a retrospective
study and therefore limitations in data collection are problematic.
Additionally, this was not a randomized control trial and hence
the groups were not entirely comparable. Finally, there was het-
erogeneity in pancreatic pathology in our sample (benign vs.
malignant vs. chronic pancreatitis), which may be a confoun-
ding factor, particularly in the analysis of non-infectious
complications.
Conclusions
Our data suggest that SPDP is a safe procedure and is associated
with the occurrence of fewer infectious and, possibly, non-
infectious complications compared with DPS, except for pancre-
atic leak. Using WBC and platelet counts as markers, patients
undergoing SPDP benefit from some preservation of splenic func-
tion. Randomized control trials are warranted to fully determine
the veracity of these assumptions. Nonetheless, we feel that SPDP
can be easily performed and has significant potential benefit.
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